The present proposal builds on several significant findings resulting from the research supported by this award. During the course of these studies we have isolated a 37KD chymotryptic fragment, containing the so-called """"""""synergistic"""""""" cell adhesion-promoting activity of fibronectin (FN). We now plan to map and characterize this site using monoclonal antibodies (MAbs), recently generated in our laboratory, and soluble proteolytic fragments or recombinant peptides in adhesion/motility promoting or blocking experiments. The putative novel cell adhesion site within the 40KD recombinant peptide, described in our progress report, will be similarly characterized; important questions are whether it acts synergistically or independently of the RGD (Gly-Arg-Asp) site, and the nature of its cell-type specificity. Once the two new cell adhesion promoting sites have been precisely mapped, fusion peptides containing multiple adhesion sites will be generated by recombinant-DNA technology and pre-screened in adhesion/motility assays for possible testing in metastasis assays. Based on our finding that murine melanoma and embryo neurites, both neural crest derived cells, bind to FN via the sites within the IIICS, an important question to be addressed is whether these sites can also promote the adhesion of cells, normal or cancer, derived from non-neuronal tissue. For example, if we are successful in identification of a novel or cell-type specific adhesion site that does not interact with receptors on bone marrow progenitor cells, then peptides containing this site will be used in bone marrow purging experimental protocols. Finally, the above peptides with adhesion/motility-promoting activity comparable to that of intact FN, e.g., the 37KD and 40KD peptides, will be tested for their antimetastatic activity; peptides effective in inhibiting metastasis will be used to investigate the potential for visualizing the disruption of FN-mediated interactions following intravenous injection of B16-F1O melanoma cells using light and electron microscopic techniques. These studies will be important in elucidating the mechanism(s) of tumor cell adhesion to fibronectin and the role of these interactions in metastasis and invasion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA045290-04A1
Application #
2091821
Study Section
Pathology B Study Section (PTHB)
Project Start
1987-07-01
Project End
1991-09-15
Budget Start
1991-04-01
Budget End
1991-09-15
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Howard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Kuzmichev, Andrei; Margueron, Raphael; Vaquero, Alejandro et al. (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A 102:1859-64
Olden, K; Breton, P; Grzegorzewski, K et al. (1991) The potential importance of swainsonine in therapy for cancers and immunology. Pharmacol Ther 50:285-90
Nagai, T; Yamakawa, N; Aota, S et al. (1991) Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol 114:1295-305
Humphries, M J; Matsumoto, K; White, S L et al. (1990) An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells. Clin Exp Metastasis 8:89-102
Breton, P; Asseffa, A; Grzegorzewski, K et al. (1990) Swainsonine modulation of protein kinase C activity in murine peritoneal macrophages. Cancer Commun 2:333-8
Humphries, M J; Obara, M; Olden, K et al. (1989) Role of fibronectin in adhesion, migration, and metastasis. Cancer Invest 7:373-93
Humphries, M J; Olden, K (1989) Asparagine-linked oligosaccharides and tumor metastasis. Pharmacol Ther 44:85-105
Humphries, M J; Matsumoto, K; White, S L et al. (1988) Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res 48:1410-5
Humphries, M J; Akiyama, S K; Komoriya, A et al. (1988) Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment. J Cell Biol 106:1289-97
Humphries, M J; Yamada, K M; Olden, K (1988) Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J Clin Invest 81:782-90

Showing the most recent 10 out of 11 publications